Publication:
Aripiprazole can a viable choice for persistant suppression of symptoms in managing chronic tic disorders and tourette's disorder through the life span: a case series

dc.contributor.coauthorTufan, Ali Evren
dc.contributor.coauthorSemerci, Bengi
dc.contributor.departmentSchool of Medicine
dc.contributor.kuauthorTaşkıran, Ali Sarper
dc.contributor.schoolcollegeinstituteSCHOOL OF MEDICINE
dc.date.accessioned2024-11-09T23:09:22Z
dc.date.issued2016
dc.description.abstractTic disorders may cause impairment both by themselves and associated comorbidities. Medications for tic disorders are indicated when tics are moderate/ severe causing severe impairment and in presence of comorbid disorders responsive to medications. Duration of improvement is still not known as the literature lacks prospective studies with a long follow-up period. This case series aims to report management of tic disorders with aripiprazole in patients with different ages. Here, we describe 8 cases with complex motor tic disorder or Tourette's Disorder in which aripiprazole was used. The ages of patients were varied, from 9 to 57 years. Mean follow-up was 19.6 weeks. Mean dose of aripiprazole for pediatric patients was 15.4 mg/ day while it was 12.5 mg/ day for adult patients. All patients benefited from treatment with aripiprazole in the long term. Our results should be supported with controlled studies.
dc.description.indexedbyWOS
dc.description.indexedbyScopus
dc.description.indexedbyTR Dizin
dc.description.issue2
dc.description.openaccessYES
dc.description.sponsoredbyTubitakEuN/A
dc.description.volume26
dc.identifier.doi10.5455/bcp.20160220032354
dc.identifier.issn1017-7833
dc.identifier.scopus2-s2.0-84975513933
dc.identifier.urihttps://doi.org/10.5455/bcp.20160220032354
dc.identifier.urihttps://hdl.handle.net/20.500.14288/9279
dc.identifier.wos383390400012
dc.keywordsAripiprazole
dc.keywordsTic
dc.keywordsTourette's disorder
dc.language.isoeng
dc.publisherKure Iletisim Grubu A S
dc.relation.ispartofKlinik Psikofarmakoloji Bulteni-Bulletin Of Clinical Psychopharmacology
dc.subjectPharmacology
dc.subjectPharmacy
dc.subjectPsychiatry
dc.titleAripiprazole can a viable choice for persistant suppression of symptoms in managing chronic tic disorders and tourette's disorder through the life span: a case series
dc.typeJournal Article
dspace.entity.typePublication
local.contributor.kuauthorTaşkıran, Ali Sarper
local.publication.orgunit1SCHOOL OF MEDICINE
local.publication.orgunit2School of Medicine
relation.isOrgUnitOfPublicationd02929e1-2a70-44f0-ae17-7819f587bedd
relation.isOrgUnitOfPublication.latestForDiscoveryd02929e1-2a70-44f0-ae17-7819f587bedd
relation.isParentOrgUnitOfPublication17f2dc8e-6e54-4fa8-b5e0-d6415123a93e
relation.isParentOrgUnitOfPublication.latestForDiscovery17f2dc8e-6e54-4fa8-b5e0-d6415123a93e

Files